Nachrichten zur Pfizer Inc. Aktie

Pfizer, BioNTech start trial of next-gen COVID-19 vaccine for broader protection

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of Protection

NEW YORK and MAINZ, GERMANY, NOVEMBER 16, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced…

Two years late: Pfizer and Moderna launch research to determine links between Covid vaccine and myocarditis

After two years of inaction and distributing the vaccines with emergency authorizations that allowed them not to do this type…

Pfizer, Roche, Lilly COVID treatments get draft recommendation from UK NHS advisors

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Top Analyst Reports for Pfizer, Goldman Sachs & General Electric

Todays Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), The Goldman Sachs Group, Inc.…

Pfizer And Moderna To Investigate Their Own Vaccines For Myocarditis Risks

Pfizer And Moderna To Investigate Their Own Vaccines For Myocarditis Risks …

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfizer Inc. - PFE

NEW YORK, Nov. 14, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Pfizer Inc. ("Pfizer"…

Global Monoclonal Antibodies Market was Valued at US$ 208.32 Bn in 2022 and is Expected to hit a Revenue of US$ 647 Bn at CAGR of 12% Between Forecast Period of 2022-32 | Future Market Insights, Inc.

Increasing Medical Tourism in Asia Pacific is Spurring Demand for Monoclonal Antibodies. The U.S. expected to account for over 46.2%…

Bridgewest Group inks deal with Pfizer to acquire injectable manufacturing plant in Western Australia

MIAMI and PERTH, Australia, Nov. 11, 2022 /PRNewswire/ -- Global private investment firm, Bridgewest Group, recognized for developing innovative companies…

EU-Behörde: Angepasster Biontech-Impfstoff auch für Kinder ab 5 Jahre

AMSTERDAM (dpa-AFX) - Die Europäische Arzneimittelbehörde EMA hat die Zulassung des an die Omikron-Variante angepassten Corona-Impfstoffes von Biontech/Pfizer auch für…

17th CSHL Double Helix Medal dinner raises $5.8 million

Cold Spring Harbor Laboratorys annual gala honors Pfizer Chairman & CEO Dr. Albert Bourla and 2020 Nobel laureate Dr. Jennifer…

Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?

Learn more about Organicell Regenerative Medicine, Inc.from this latest report.During the peak of the deadly COVID-19 pandemic, one novel therapeutic…

Pfizer/ BioNTech win EU nod to use Omicron booster in children

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer, BioNTech BA.4/BA.5-adapted booster gets CHMP recommendation for 5-11 year olds in EU

Pfizer Inc. and Germany-based partner BioNTech SE said Thursday that their booster dose of the omicron BA.4/BA.5-adapted bivalent…

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union

NEW YORK and MAINZ, GERMANY, November 10, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced…

NCCN Announces Funding for Bladder Cancer Research Projects, in Collaboration with Pfizer and EMD Serono

The National Comprehensive Cancer Networks Oncology Research Program selects projects focused on improving patient care and outcomes in locally advanced…

Investmentidee: Vontobel-Aktienanleihe auf BioNTech, Moderna, Pfizer - Potenzial im Onkologie-Bereich - Anleiheanalyse

München (www.anleihencheck.de) - Für Vontobel sind die Aktien von BioNTech (ISIN US09075V1026/ WKN A2PSR2), Moderna (ISIN US60770K1079/ WKN A2N9D9) und…

Form 10-Q PFIZER INC For: Oct 02

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfizer Inc. - PFE

New York, New York--(Newsfile Corp. - November 9, 2022) - Pomerantz LLP is investigating claims on behalf of investors of…

This Could Be a Huge Opportunity for Pfizer

Is Pfizer a good contrarian buy?...…

Pfizer (PFE) to Enforce 2-3 Days of Weekly Office Work in January

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know

Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…

Pfizer COVID-19 pill cuts risk of long COVID by 26% - study

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BioNTech earnings drop but forecast for vaccine income grows

BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported that third-quarter earnings are close to half…

BioNTech hebt Prognose an – Aktie jetzt kaufen?

Nach ihrem Run im Vorfeld der heute vorgelegten neuen Quartalszahlen gibt die BioNTech-Aktie (WKN: A2PSR2) zurzeit kräftig ab, vorbörslich in…

BioNTech: Starke News im Doppelpack – Aktie mit wichtigem Signal

Die Aktie von BioNTech hat am Freitag kräftig Gas gegeben. Zum einen profitierte das Papier von der Meldung, dass Bundeskanzler…

Pfizer: what’s next for the Covid-19 vaccine maker and its US$28 billion war chest?

Pfizer’s Covid-19 vaccine saw the pharmaceutical company become the world’s most visible drug maker, but with its stock falling in…

Haleon third-quarter update is big date for Pfizer stock overhang

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Umsatzeinbruch nach Übernahme: Musk droht abtrünnigen Twitter-Werbekunden

Grosskonzerne wie VW, Pfizer und Mondelez haben nach der Twitter-Übernahme durch Elon Musk angekündigt, die Werbung beim Kurznachrichtendienst auszusetzen. Das…

Pfizer/BioNTech Omicron booster is safe despite bubble formation – Swissmedic

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a day

Pfizer Inc. and Germany-based partner BioNTech said updated trial data for their omicron BA.4/BA.5-adapted bivalent booster showed a "substantially higher"…

Pfizer releases more data indicating omicron boosters are better than old Covid shots

People older than 55 who received the new Covid booster had about four times more antibodies targeting omicron BA.5 than…

What Cramer is watching Friday — Starbucks soars on China hope, jobs growth still strong

China appears to be breaking the ice on zero-Covid. Foreigners there to get BioNTech (BNTX)-Pfizer (PFE) mRNA vaccine....…

Pfizer Says Updated Booster Shot Sparks Stronger Immune Response Versus Original Vaccine—As Uptake Slows Drastically

Protective antibodies against the dominant BA.5 omicron variant were “substantially higher” after the updated booster shot compared to the original…

Pfizer, BioNTech gain as updated data supports use of Omicron booster in adults

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer, BioNTech Reveal Updated Data For Omicron BA.4/BA.5-Adapted Bivalent Booster

NEW YORK CITY (dpa-AFX) - Drug major Pfizer Inc. (PFE) and German partner BioNTech SE (BNTX) announced Friday updated data…

Nach starken News von Pfizer: Jetzt grünes Licht für Sanofi und Astrazeneca

Eine jahrelange Zusammenarbeit der Pharmakonzerne Sanofi und Astrazeneca für ein Mittel gegen einen gefährlichen Atemwegsinfekt im frühen Kindesalter zahlt sich…

Pfizer Says New Covid Booster Works Better Than Old One In Study

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer, BioNTech stocks rally after announcing positive trial data on BA.4/BA.5 bivalent booster shot

Pfizer Inc. and Germany-based partner BioNTech SE said new data from a Phase 2/3 trial showed that the…

Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine

NEW YORK and MAINZ, GERMANY, November 4, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced…

dpa-AFX ProFeed